ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Huoxin Pill Reduces Myocardial Ischemia Reperfusion Injury in Rats via TLR4/NFκB/NLRP3 Signaling Pathway

Cao, Ce; Qi, Yu-tong; Wang, Ao-ao; Wang, Zi-yan; Liu, Zi-xin; Meng, Hong-xu; Li, Lei; Liu, Jian-xun*广东药学院
Chinese Journal of Integrative Medicine2023-12DOI: 10.1007/s11655-023-3640-1
1被引9阅读
引用收藏
分享

摘要

Objective: To explore the protective effect of Huoxin Pill (HXP) on acute myocardial ischemia-reperfusion (MIRI) injury in rats. Methods: Seventy-fifive adult SD rats were divided into the sham-operated group, model group, positive drug group (diltiazem hydrochloride, DH), high dose group (24 mg/kg, HXP-H) and low dose group (12 mg/kg, HXP-L) of Huoxin Pill (n= 15 for every group) according to the complete randomization method. After 1 week of intragastric administration, the left anterior descending coronary artery of the rat's heart was ligated for 45 min and reperfused for 3 h. Serum was separated and the levels of creatine kinase (CK), creatine kinase isoenzyme (CK-MB) and lactate dehydrogenase (LDH), superoxide dismutase (SOD), and malondialdehyde (MDA), hypersensitive C-reactive protein (hs-CRP) and interleukin-1 beta (IL-1 beta) were measured. Myocardial ischemia rate, myocardial infarction rate and myocardial no-reflow rate were determined by staining with Evans blue and 2,3,5-triphenyltetrazolium chloride (TTC). Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine (BATMAN) databases were used to screen for possible active compounds of HXP and their potential therapeutic targets; the results of anti-inflammatory genes associated with MIRI were obtained from GeneCards, Drugbank, Online Mendelian Inheritance in Man (OMIM), and Therapeutic Target Datebase (TTD) databases was performed; Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment were used to analyze the intersected targets; molecular docking was performed using AutoDock Tools. Western blot was used to detect the protein expression of Toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF kappa B)/NOD-like receptor protein 3 (NLRP3). Results: Compared with the model group, all doses of HXP signifificantly reduced the levels of LDH, CK and CK-MB (P< 0.05, P< 0.01); HXP signifificantly increased serum activity of SOD (P< 0.05, P< 0.01); all doses of HXP signifificantly reduced the levels of hs-CRP and IL-1 beta (P< 0.05, P< 0.01) and the myocardial infarction rate and myocardial no-reflflow rate ( P< 0.01). GO enrichment analysis mainly involved positive regulation of gene expression, extracellular space and identical protein binding, KEGG pathway enrichment mainly involved PI3K-Akt signaling pathway and lipid and atherosclerosis. Molecular docking results showed that kaempferol and luteolin had a better affifinity with TLR4, NF kappa B and NLRP3 molecules. The protein expressions of TLR4, NF kappa B and NLRP3 were reduced in the HXP group (P< 0.01). Conclusions: HXP has a significant protective effect on myocardial ischemia-reperfusion injury in rats, and its effect may be related to the inhibition of redox response and reduction of the inflammatory response by inhibiting the TLR4/NF kappa B/NLRP3 signaling pathway.

学科与关键词

关键词
Houxin Pillmyocardial ischemia-reperfusion injuryTLR4/NF kappa B/NLRP3 signaling pathwaynetwork pharmacologymolecular docking
相关
加载中…
  • Integrated chemical profiling, network pharmacology and pharmacological evaluation to explore the potential mechanism of Xinbao pill against myocardial ischaemia-reperfusion injury
    Yang, Ying; Chen, Ting; Liu, Jiaming; Chen, Sixuan; Cai, Rongqing; Wu, Liqiong; Hu, Jiexiong; Lin, Qiongying; Qi, Xiaoxiao; Liu, Zhongqiu*; Cheng, Yuanyuan*PHARMACEUTICAL BIOLOGY, 2022, 60(1): 255-273.被引 5
  • Buyang Huanwu Decoction suppresses cardiac inflammation and fibrosis in mice after myocardial infarction through inhibition of the TLR4 signalling pathway
    Zhang, Guoyong; Han, Xin; Xu, Tong; Liu, Min; Chen, Guanghong; Xie, Lingpeng; Xu, Honglin; Hua, Yue; Pang, Mingjie; Hu, Changlei; Wu, Yuting*; Liu, Bin*; Zhou, Yingchun*Journal of Ethnopharmacology, 2024, 320: 117388.被引 1
  • QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
    Li, Meng; Wang, Yueyao; Qi, Zhongwen; Yuan, Zhuo; Lv, Shichao; Zheng, Yawei; Yan, Zhipeng; Wang, Mingyang; Fu, Huanjie; Fan, Xinbiao; Ji, Nan; Liu, Ming*; Fang, Zhuyuan*Frontiers in Pharmacology, 2022, 13: 981206.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Chinese Journal of Integrative Medicine
发表日期
2023-12
卷期
第 29 卷, 第 12 期
页码
1066-1076
DOI
10.1007/s11655-023-3640-1
语言
ENGLISH
期刊收录
CAST-E
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82174015, 82030124]; Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences [CI2021A04609]

作者

  • C

    Cao, Ce (第一作者)

    xiyuan hosp · guangdong pharmaceut univ

  • Q

    Qi, Yu-tong

    xiyuan hosp

查看全部 8 位作者收起作者
  • W

    Wang, Ao-ao

    xiyuan hosp

  • W

    Wang, Zi-yan

    xiyuan hosp

  • L

    Liu, Zi-xin

    xiyuan hosp

  • M

    Meng, Hong-xu

    xiyuan hosp

  • L

    Li, Lei

    xiyuan hosp

  • L

    Liu, Jian-xun (通讯)

    guangdong pharmaceut univ · xiyuan hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417